CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iyer, A.
Right arrow Articles by Vande Woude, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iyer, A.
Right arrow Articles by Vande Woude, G. F.

Cell Growth & Differentiation, Vol 1, Issue 2 87-95, Copyright © 1990 by American Association of Cancer Research


ARTICLES

Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene

A Iyer, TE Kmiecik, M Park, I Daar, D Blair, KJ Dunn, P Sutrave, JN Ihle, M Bodescot and GF Vande Woude
Rush Presbyterian St. Luke's Medical Center, Medical Oncology Department, Chicago, Illinois 60612.

A 6.7-kilobase met complementary DNA (cDNA) was isolated from a pcD cDNA library prepared from C3H mouse fibroblast cell line polyadenylated RNA. Sequence analysis of 6.7-kilobase met cDNA insert revealed that it contained the entire open reading frame and shared an overall homology of 88.1% with the human met gene. Using the mouse met cDNA as probe, high levels of met expression were observed in the kidney, brain, lung, skin, and embryonic tissue as well as in several factor responsive mouse myeloid cell lines. Under SV40 promoter control, the mouse met protooncogene cDNA in the pCD vector was able to transform NIH 3T3 cells. These transformed cells possess multiple copies of mouse met cDNA and exhibit properties of malignant cells, including growth in soft agar and induction of tumors in nude mice. Tumor explant cell lines analyzed by Western blot also reveal the presence of high levels of Mr 170,000 and 140,000 met protein product(s).


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Gordin, M. Tesio, S. Cohen, Y. Gore, F. Lantner, L. Leng, R. Bucala, and I. Shachar
c-Met and Its Ligand Hepatocyte Growth Factor/Scatter Factor Regulate Mature B Cell Survival in a Pathway Induced by CD74
J. Immunol., August 15, 2010; 185(4): 2020 - 2031.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Toschi and P. A. Janne
Single-Agent and Combination Therapeutic Strategies to Inhibit Hepatocyte Growth Factor/MET Signaling in Cancer
Clin. Cancer Res., October 1, 2008; 14(19): 5941 - 5946.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
C. N. Wrobel, J. Debnath, E. Lin, S. Beausoleil, M. F. Roussel, and J. S. Brugge
Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture
J. Cell Biol., April 26, 2004; 165(2): 263 - 273.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. V. Hay, B. Cao, R. S. Skinner, L.-M. Wang, Y. Su, J. H. Resau, B. S. Knudsen, M. F. Gustafson, H.-M. Koo, G. F. V. Woude, et al.
Radioimmunoscintigraphy of Human Met-Expressing Tumor Xenografts Using Met3, a New Monoclonal Antibody
Clin. Cancer Res., September 1, 2003; 9(10): 3839s - 3844s.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
J. A. Recio, F. P. Noonan, H. Takayama, M. R. Anver, P. Duray, W. L. Rush, G. Lindner, E. C. De Fabo, R. A. DePinho, and G. Merlino
Ink4a/Arf Deficiency Promotes Ultraviolet Radiation-induced Melanomagenesis
Cancer Res., November 15, 2002; 62(22): 6724 - 6730.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Yu and G. Merlino
Constitutive c-Met Signaling through a Nonautocrine Mechanism Promotes Metastasis in a Transgenic Transplantation Model
Cancer Res., May 1, 2002; 62(10): 2951 - 2956.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Maulik, T. Kijima, P. C. Ma, S. K. Ghosh, J. Lin, G. I. Shapiro, E. Schaefer, E. Tibaldi, B. E. Johnson, and R. Salgia
Modulation of the c-Met/Hepatocyte Growth Factor Pathway in Small Cell Lung Cancer
Clin. Cancer Res., February 1, 2002; 8(2): 620 - 627.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. A. Furge, D. Kiewlich, P. Le, M. N. Vo, M. Faure, A. R. Howlett, K. E. Lipson, G. F. V. Woude, and C. P. Webb
Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase
PNAS, September 11, 2001; 98(19): 10722 - 10727.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
R. Wang, L. D. Ferrell, S. Faouzi, J. J. Maher, and J. M. Bishop
Activation of the Met Receptor by Cell Attachment Induces and Sustains Hepatocellular Carcinomas in Transgenic Mice
J. Cell Biol., May 28, 2001; 153(5): 1023 - 1034.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Otsuka, J. Jakubczak, W. Vieira, D. P. Bottaro, D. Breckenridge, W. J. Larochelle, and G. Merlino
Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis
Mol. Cell. Biol., March 15, 2000; 20(6): 2055 - 2065.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Koochekpour, M. Jeffers, P. H. Wang, C. Gong, G. A. Taylor, L. M. Roessler, R. Stearman, J. R. Vasselli, W. G. Stetler-Stevenson, W. G. Kaelin Jr., et al.
The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells
Mol. Cell. Biol., September 1, 1999; 19(9): 5902 - 5912.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
O. Bogler, M. Nagane, J. Gillis, H-J. Su Huang, and W. K. Cavenee
Malignant Transformation of p53-deficient Astrocytes Is Modulated by Environmental Cues in Vitro
Cell Growth Differ., February 1, 1999; 10(2): 73 - 86.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
D. Ronen, R. T. Altstock, M. Firon, L. Mittelman, T. Sobe, J. H. Resau, G. F. Vande Woude, and I. Tsarfaty
Met-HGF/SF Mediates Growth Arrest and Differentiation in T47D Breast Cancer Cells
Cell Growth Differ., February 1, 1999; 10(2): 131 - 140.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Jeffers, M. Fiscella, C. P. Webb, M. Anver, S. Koochekpour, and G. F. Vande Woude
The mutationally activated Met receptor mediates motility and metastasis
PNAS, November 24, 1998; 95(24): 14417 - 14422.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. P. Webb, L. Van Aelst, M. H. Wigler, and G. F. Vande Woude
Signaling pathways in Ras-mediated tumorigenicity and metastasis
PNAS, July 21, 1998; 95(15): 8773 - 8778.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Jeffers, L. Schmidt, N. Nakaigawa, C. P. Webb, G. Weirich, T. Kishida, B. Zbar, and G. F. Vande Woude
Activating mutations for the Met tyrosine kinase receptor in human cancer
PNAS, October 14, 1997; 94(21): 11445 - 11450.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. Anastasi, S. Giordano, O. Sthandier, G. Gambarotta, R. Maione, P. Comoglio, and P. Amati
A Natural Hepatocyte Growth Factor/Scatter Factor Autocrine Loop in Myoblast Cells and the Effect of the Constitutive Met Kinase Activation on Myogenic Differentiation
J. Cell Biol., June 2, 1997; 137(5): 1057 - 1068.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Takayama, W. J. LaRochelle, R. Sharp, T. Otsuka, P. Kriebel, M. Anver, S. A. Aaronson, and G. Merlino
Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor
PNAS, January 21, 1997; 94(2): 701 - 706.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. P. Webb, K. Lane, A. P. Dawson, G. F. Vande Woude, and R. M. Warn
C-Met signalling in an HGF/SF-insensitive variant MDCK cell line with constitutive motile/invasive behaviour
J. Cell Sci., September 1, 1996; 109(9): 2371 - 2381.
[Abstract] [PDF]


Home page
DevelopmentHome page
X. Yang, K Vogan, P Gros, and M Park
Expression of the met receptor tyrosine kinase in muscle progenitor cells in somites and limbs is absent in Splotch mice
Development, July 1, 1996; 122(7): 2163 - 2171.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
J. V. Soriano, M. S. Pepper, T. Nakamura, L. Orci, and R. Montesano
Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells
J. Cell Sci., February 1, 1995; 108(2): 413 - 430.
[Abstract] [PDF]


Home page
J Biol ChemHome page
L. Naldini, E. Vigna, A. Bardelli, A. Follenzi, F. Galimi, and P. M. Comoglio
Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction
J. Biol. Chem., January 13, 1995; 270(2): 603 - 611.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
I Tsarfaty, S Rong, J. Resau, S Rulong, P. da Silva, and G. Vande Woude
The Met proto-oncogene mesenchymal to epithelial cell conversion
Science, January 7, 1994; 263(5143): 98 - 101.
[Abstract] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
S. Rong and G.F. Vande Woude
Autocrine Mechanism for met Proto-oncogene Tumorigenicity
Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 629 - 636.
[Abstract] [PDF]


Home page
ScienceHome page
I Tsarfaty, J. Resau, S Rulong, I Keydar, D. Faletto, and G. Vande Woude
The met proto-oncogene receptor and lumen formation
Science, August 28, 1992; 257(5074): 1258 - 1261.
[Abstract] [PDF]


Home page
ScienceHome page
D. Bottaro, J. Rubin, D. Faletto, A. Chan, T. Kmiecik, G. Vande Woude, and S. Aaronson
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
Science, February 15, 1991; 251(4995): 802 - 804.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. A. Furge, D. Kiewlich, P. Le, M. N. Vo, M. Faure, A. R. Howlett, K. E. Lipson, G. F. V. Woude, and C. P. Webb
Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase
PNAS, September 11, 2001; 98(19): 10722 - 10727.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1990 by the American Association of Cancer Research.